Key facts
- Fermeate’s last known valuation is $8.2M (Mar 2026).
- It has raised $2.6M across 1 recorded rounds; the latest was Seed Round ($2.5M) in Mar 2026.
- Notable investors include SOSV, IndieBio, Newfund Management, Heuristic Capital Partners, BEAM Circular — 7 tracked in total.
- Fermeate has filed 1 Form D with the SEC, most recently Apr 2026 ($2.5M sold to 9 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Fermeate
Funding rounds
1 roundsAbout Fermeate
Developer of a light-controlled microbial fermentation technology intended for sustainable chemical production purposes. The company's platform integrates optogenetic control of cell metabolism with advanced hardware and AI/ML-driven monitoring to dynamically regulate metabolic flux, increase yields without compromising microbial growth, extend high-productivity fermentation phases, and adapt to continuous production processes, enabling biomanufacturers to improve economics, reduce greenhouse gas emissions, and scale more sustainable bio-based production.
- Sector
- Business Products and Services (B2B)
- HQ
- San Francisco, CA, United States
- Founded
- 2024
- Employees
- 5
- Website
- fermeate.com/
- Ownership
- Privately Held (backing)
Fermeate doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Fermeate shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Fermeate in its N-PORT filings yet. We sweep new filings monthly.